NCT04576208: A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788 |
|
|
| Withdrawn | 2 | 0 | NA | TAK-788, AP32788, Mobocertinib, Antidiarrheal prophylaxis | Takeda | Non-Small Cell Lung Cancer (NSCLC) | 07/22 | 07/22 | | |